Trial Profile
oMARIgliptin once A week dpp-4 inhibitor post-marketinG surveillance on safety and Efficacy
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 06 Oct 2021
Price :
$35
*
At a glance
- Drugs Omarigliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Therapeutic Use
- Acronyms MARIAGE
- Sponsors MSD KK
- 20 Feb 2017 New trial record